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OBJECTIVE — Waist and hip circumferences have been shown to have independent and
opposite associations with glucose levels. Waist circumference is positively associated with
glucose levels, whereas hip circumference is negatively associated. It is unclear which tissues are
involved in the pathophysiological mechanism causing these associations. The main goal was to
determine which tissue in the trunk and legs, fat or lean tissue, is associated with measures of
glucose metabolism.
RESEARCH DESIGN AND METHODS — In 623 participants of the third examination
of the Hoorn Study, whole-body dual-energy X-ray absorptiometry was performed to determine
fat and lean soft-tissue mass in the trunk and legs. Fasting and 2-h postload glucose levels after
75-g oral glucose tolerance test (OGTT) were determined. After exclusion of known diabetic
patients, cross-sectional analyses were performed in 275 men aged 60–87 years (140 with
normal glucose metabolism, 92 with impaired glucose metabolism; and 43 with diabetes) and in
281 women (148 with normal glucose metabolism, 90 with impaired glucose metabolism, and
43 with diabetes).
RESULTS — Greater trunk fat mass was associated with higher glucose levels after adjustment
for age, trunk lean mass, leg lean mass, and leg fat mass. Standardized  (95% CI) in men were
0.44 (0.25–0.64) for fasting and 0.41 (0.22–0.60) for postload glucose. For women, these values
were 0.49 (0.35 – 0.63) and 0.47 (0.33 – 0.61), respectively. In contrast, in the same regression
models, a larger leg fat mass was associated with lower glucose levels. Standardized  in men
were 0.24 (0.43 to 0.05) and 0.12 (0.31 to 0.07) and in women 0.24 (0.37 to
0.10) and 0.27 (0.40 to 0.13) for fasting and postload glucose, respectively. In these
models, larger leg lean mass was also associated with lower glucose levels but was only statisti-
cally significant in men.
CONCLUSIONS — If trunk fat is taken into account, accumulation of fat in the legs seems
to be protective against a disturbed glucose metabolism, particularly in women. Further research
is needed to unravel underlying pathophysiological mechanisms.
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Obesity, particularly abdominal obe-sity, is associated with increasedrisk of insulin resistance and type 2
diabetes. The pathophysiological mecha-
nisms involved in the development of
these conditions are not completely un-
derstood. The idea that an increased re-
lease of free fatty acids (FFAs) from
visceral fat into the portal vein plays a ma-
jor role in the development of insulin re-
sistance in abdominal obesity is now
widely accepted (1–3). This, however,
does not preclude the possibility that
other tissues are involved.
In epidemiologic studies, abdominal
obesity or visceral fat is often estimated by
the measurement of waist circumference
alone or by measurement of the waist-to-
hip ratio (WHR) or waist-to-thigh ratio
(WTR). Several studies, however, have
shown that the association between WHR
or WTR and glucose metabolism of type 2
diabetes was not only due to a larger waist
circumference but also due to a smaller
hip or thigh circumference (4–8). This
could indicate a protective role for a larger
hip circumference to high glucose levels.
To determine whether this protective ef-
fect of a larger hip or thigh circumference
is due to a higher lean mass or to a higher
fat mass in the gluteal/femoral region, ac-
curate assessment of body composition is
necessary.
To investigate how fat and lean tissue
are represented by the waist and hip cir-
cumferences, we first studied the associa-
tions of waist and hip circumferences
with fat and lean tissue mass in the trunk
and in the legs as measured by dual-
energy X-ray absorptiometry (DXA). The
main goal of the present study was to in-
vestigate the association of fat and lean
tissue mass in the trunk and in the legs
with glucose metabolism. The study was
performed within the third follow-up ex-
amination of the Hoorn Study, a popula-
tion-based cohort study of glucose
tolerance.
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RESEARCH DESIGN AND
METHODS — The Hoorn Study is a
population-based cohort study of glucose
metabolism and its complications that
started in 1989 and has been described
earlier (9). It consisted of 2,484 men and
women aged 50–75 years at baseline. In
2000–2001, a third examination was per-
formed among surviving participants
who gave their permission to be recon-
tacted. We invited all participants who
had diabetes, as determined by a 75-g oral
glucose tolerance test (OGTT) or by dia-
betes treatment (n  176) at the second
examination of the entire cohort in 1996–
1998 (10). We also invited random sam-
ples of participants who had normal
glucose tolerance (n  705) or impaired
glucose tolerance (n  193) in 1996–
1998. Of 1,074 individuals invited, 648
persons (60.3%) participated. The main
reasons for not participating in the 2000–
2001 follow-up examination were lack of
interest (30%) or comorbidity (23%).
Other reasons were advanced age (7%),
unwillingness to travel (6%), participa-
tion considered too time-consuming
(6%), and miscellaneous reasons (15%);
13% individuals gave no reason for refus-
ing to participate in the follow-up
examination.
For the present study, cross-sectional
data of the 2000–2001 follow-up exami-
nation were analyzed. Of the 648 partici-
pants, 25 individuals were excluded
because of missing DXA data. Another
eight individuals were excluded because
glucose tolerance data were incomplete.
Participants already known to have diabe-
tes (n  59) were also excluded from the
statistical analyses because treatment
could potentially influence the relations
under consideration. Therefore, our final
study sample consisted of 556 subjects
(275 men and 281 women). The study
protocol was approved by the Ethical Re-
view Committee of the VU University
Medical Center, and all participants gave
their written informed consent.
Body composition
Whole-body DXA was performed using
the fan beam technology (QDR-2000,
software version 7.20D; Hologic, Brus-
sels, Belgium). The software provides es-
timates of lean tissue mass, fat mass, and
bone mineral mass for the total body and
for standard body regions. With the use of
specific anatomic landmarks, regions of
the head, trunk, arms, and legs were dis-
tinguished as shown in Fig. 1. In the anal-
yses, we used fat and lean soft-tissue mass
from the trunk and legs.
Anthropometry and lifestyle
Weight and height were measured in
barefoot subjects wearing light clothing
only. BMI was calculated as weight di-
vided by height squared (kg/m2). Waist
circumference was measured at the level
midway between the lowest rib margin
and the iliac crest, and the hip circumfer-
ence at the widest level over the greater
trochanters. WHR was calculated as waist
circumference divided by hip circumfer-
ence. Self-reported information on phys-
ical activity (min/week), alcohol intake (g/
day), and smoking (yes/no) was obtained
by questionnaires.
Glucose metabolism
All participants underwent a single 75-g
OGTT. Fasting glucose and 2-h postload
glucose after OGTT were measured in
plasma with the hexokinase method
(Roche Diagnostics, Mannheim, Ger-
many). Glucose tolerance status was de-
fined according to the World Health
Organization (WHO) criteria (11). Sub-
jects were classified as having normal glu-
cose metabolism, impaired glucose
metabolism (i.e., impaired fasting glucose
or impaired glucose tolerance), or diabe-
tes. Fasting insulin was measured in
plasma by a two-site immunoradiometric
test (Medgenix Diagnostics, Fleurus, Bel-
gium) and homeostasis model assessment
of insulin resistance (HOMA-IR) was cal-
culated (12).
Statistical analyses
All analyses were performed separately
for men and women because of the statis-
tically significant effect modification by
sex of the relations under consideration.
To test for linear trend in study sample
characteristics over categories of glucose
metabolism, a linear regression model
was used; the glucose tolerance category
was used as a linear explanatory variable.
Values are expressed as means  SD for
normally distributed variables and as me-
dians (interquartile range) in case of
skewed distribution.
To study the association of the re-
gional fat and lean mass measured by
DXA (independent variables) with the
waist and hip circumferences by anthro-
pometry (dependent variables), multiple
regression analyses were performed. The
associations of the regional fat and lean
tissue mass with the more commonly
used WHR and BMI were also investi-
gated. Effect modification by sex, glucose
tolerance status, and age was evaluated by
adding product terms to the model.
The contribution of regional fat and
lean tissue mass to fasting glucose, post-
load glucose, or HOMA-IR (ln-trans-
formed) was tested using multiple
regression analyses with adjustment for
age. Residual plots were examined to
check for violation of the normality as-
sumptions. Effect modification by sex and
glucose metabolism status was evaluated
by adding product terms to the model. To
facilitate direct comparisons, results of
the regression analyses are reported as
standardized . A standardized  of 0.1
indicates that when the independent vari-
able increases by 1 SD, the dependent
variable increases by 0.1 SD. We consid-
ered the stability of the regression models
to be disturbed by multicolinearity if the
tolerance was0.1. The tolerance is a sta-
tistic used to determine how much the
independent variables are linearly related
to one another. It is calculated as 1 – R2 for
an independent variable when it is pre-
dicted by the other independent variables
already included in the model. All statis-
tical analyses were performed using SPSS
for Windows (version 10.1; SPSS, Chi-
cago, IL).
RESULTS — The characteristics of the
study sample by sex and glucose metabo-
lism status are shown in Table 1. All an-
thropometric measures in both sexes, and
age in women, were significantly and pos-
Figure 1—Standard regions of a DXA scan: 1,
head; 2, trunk; 3, arms; 4, legs.
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itively associated with a worse glucose
metabolism when tested for linear trend,
except for hip circumference in men. Of
the DXA measurements, the fat mass in
the trunk as well as in the legs in men and
the fat and lean mass in the trunk in
women were significantly and positively
associated with worse glucose metabo-
lism. After adjustment for age, the trunk
fat mass and the leg fat mass remained
positively associated with worse glucose
metabolism status in men. In women, in
addition to trunk fat and lean mass, leg
lean mass was also positively associated
with worse glucose metabolism status af-
ter adjustment for age (data not shown).
Anthropometry
The associations of the fat and lean mass
in the trunk and legs with anthropometric
measures are shown in Table 2. Waist cir-
cumference was strongly positively asso-
ciated with trunk fat, whereas hip
circumference was positively associated
with both leg fat and leg lean mass. WHR
was most strongly and positively associ-
ated with trunk fat mass and was nega-
tively associated with both lean and fat
mass in the legs. In contrast to the WHR,
BMI was mainly associated with fat mass,
especially trunk fat. When age was added
to these models, the associations did not
change substantially (data not shown).
There was no significant effect modifica-
tion by glucose tolerance status or age.
Glucose metabolism
Table 3 shows the results of multiple lin-
ear regression analyses involving fat and
lean tissue mass in the trunk and legs in
relation to fasting and postload glucose
levels and HOMA-IR. After adjustment
for age, leg lean and leg fat mass, and each
other, larger trunk fat mass as well as
larger trunk lean mass were associated
with higher fasting glucose (model 1).
However, in the same regression model,
larger leg fat and leg lean mass were asso-
ciated with lower fasting glucose. In both
sexes, only larger trunk fat mass, and not
trunk lean mass, was significantly associ-
ated with higher postload glucose levels
(model 2). In contrast, larger leg fat mass
was associated with lower postload glu-
cose, but was only statistically significant
in women. Similar results were found for
ln-transformed HOMA-IR (model 3).
Trunk fat mass was the strongest inde-
pendent predictor of glucose levels andT
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HOMA-IR. Adjustment for height did not
change the associations (data not shown).
In addition, adjustment for physical activ-
ity, alcohol intake, and smoking did not
change the results (data not shown).
There was no statistically significant effect
modification by glucose tolerance status,
except that the associations of trunk fat
and trunk lean mass with fasting glucose
was stronger in diabetic subjects (data not
shown). Among the four independent
variables used in the linear regression
models, the highest correlation (Pearson)
was between lean mass in the trunk and
lean mass in the legs (0.825 in men and
0.815 in women). The stability of the re-
gression models, however, was not dis-
turbed by multicolinearity. Residual plots
were not disturbed, and similar results
were found when glucose levels were ln-
transformed and included as study out-
come (data not shown).
CONCLUSIONS — In this study, we
show that waist or hip circumference does
not simply represent the amount of fat at
that region. Although the waist circumfer-
ence is mainly associated with fat mass in
the trunk, the hip circumference is
strongly associated with both fat mass and
lean mass in the legs, particularly in men.
Furthermore, our study shows that, as ex-
pected, larger trunk fat mass is associated
with higher glucose levels. In contrast, ac-
cumulation of fat in the legs was associ-
ated with lower glucose levels. In men,
large lean mass in the legs seems to have
an additional independent protective
effect.
The recognition of the importance of
upper body versus lower body obesity in
diabetes and cardiovascular disease by
Vague in 1956 led to the development of
the WHR and WTR measurements (13).
Because it was found in the 1980s that the
WHR was more closely associated with
intra-abdominal fat than with subcutane-
ous fat, associations of WHR with disease
have generally been interpreted as caused
by the increased accumulation of visceral
fat (14,15). Whether WHR also repre-
sents other body tissues was unclear. Data
on direct comparison between anthropo-
metrically measured circumferences, par-
ticularly hip circumference and WHR,
and regional body composition, includ-
Table 2—Independent associations of trunk fat and lean mass with the waist circumference, of
leg fat and lean mass with the hip circumference, and of fat and lean mass in the trunk and legs
with WHR and BMI
Men Women
* 95% CI * 95% CI
Waist circumference
Trunk fat 0.81‡ 10.76–0.87 0.82‡ 0.77–0.87
Trunk lean 0.23‡ 0.18–0.29 0.19‡ 0.14–0.25
Hip circumference
Leg fat 0.68‡ 0.62–0.74 0.67‡ 0.59–0.74
Leg lean 0.41‡ 0.35–0.53 0.24‡ 0.17–0.32
WHR
Trunk fat 0.78‡ 0.63–0.93 0.69‡ 0.60–0.81
Trunk lean 0.31‡ 0.14–0.48 0.21† 0.05–0.37
Leg fat 0.22† 0.27 to 0.07 0.42‡ 0.54 to 0.29
Leg lean 0.40‡ 0.56 to 0.23 0.06 0.23 to 0.10
BMI
Trunk fat 0.57‡ 0.48–0.66 0.67‡ 0.61–0.73
Trunk lean 0.19‡ 0.09–0.29 0.02 0.06 to 0.10
Leg fat 0.24‡ 0.14–0.33 0.28‡ 0.22–0.34
Leg lean 0.09 0.01–0.19 0.08† 0.00–0.16
*, standardized , †P  0.05, ‡P  0.001.
Table 3—Independent associations of trunk fat, trunk lean mass, leg fat, and leg lean mass (adjusted for each other) with fasting glucose levels
(model 1), with postload glucose levels (model 2), and with HOMA-IR (model 3), additionally adjusted for age
Men Women
* 95% CI P * 95% CI P
Model 1: fasting glucose
Trunk fat mass 0.44 0.25–0.64 0.00 0.49 0.35–0.63 0.00
Trunk lean mass 0.26 0.05–0.46 0.02 0.27 0.09–0.45 0.00
Leg fat mass 0.24 0.43 to 0.05 0.01 0.24 0.37 to 0.10 0.00
Leg lean mass 0.27 0.48 to 0.06 0.01 0.15 0.34 to 0.03 0.11
Model 2: postload glucose
Trunk fat mass 0.41 0.22–0.60 0.00 0.47 0.33–0.61 0.00
Trunk lean mass 0.02 0.22 to 0.19 0.89 0.08 0.10 to 0.25 0.38
Leg fat mass 0.12 0.31 to 0.07 0.23 0.27 0.40 to 0.13 0.00
Leg lean mass 0.12 0.33 to 0.10 0.28 0.04 0.22 to 0.14 0.69
Model 3: In-HOMA-IR
Trunk fat mass 0.59 0.41–0.76 0.00 0.65 0.52–0.77 0.00
Trunk lean mass 0.16 0.03 to 0.36 0.10 0.19 0.03–0.34 0.02
Leg fat mass 0.18 0.35 to 0.00 0.05 0.19 0.30 to 0.06 0.00
Leg lean mass 0.18 0.38 to 0.01 0.07 0.00 0.16 to 0.16 0.98
*, standardized .
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ing both fat and lean tissue, are limited,
and little is known about the influence of
sex and age on this relationship. Only one
previous study of 24 men showed a neg-
ative association between WHR and the
thigh muscle area by computed tomogra-
phy, suggesting that high WHR may also
result from low muscle mass in the legs
(16). In our study, we show that the waist
and hip circumferences are not only asso-
ciated with fat mass at the respective body
regions. The hip circumference, a surro-
gate marker of lower body obesity, was
also strongly associated with leg lean
mass, particularly in men. WHR was pos-
itively associated with trunk fat mass but
also negatively associated with both lean
and fat mass at the legs.
Because our study showed that the
anthropometric measures seemed to rep-
resent different tissues, we examined
which tissue would be responsible for the
earlier observed associations between an-
thropometric measures and glucose toler-
ance. Larger waist circumference but
smaller hip circumference has been asso-
ciated with worse glucose tolerance status
or diabetes in several studies (4–8). From
the present study, we can conclude that,
particularly in the trunk, fat tissue is as-
sociated with unfavorable glucose metab-
olism. This could be consistent with the
established role of visceral fat, which re-
leases FFA directly into the portal vein,
causing disturbances in glucose metabo-
lism (1–3). Some studies, however, found
that subcutaneous abdominal fat is more
closely related to insulin resistance than
visceral fat (17,18).
In contrast to fat mass in the trunk, fat
mass in the legs was negatively associated
with glucose levels and HOMA-IR. These
data are consistent with recently pub-
lished data on the contributions of re-
gional fat mass by DXA to several
cardiovascular risk factors in women,
such as insulin resistance and dyslipide-
mia (19,20). It has been suggested that fat
tissue in the gluteal or femoral region
plays a protective role, because adipo-
cytes in these regions are less sensitive to
lipolytic stimuli (21,22). Therefore, these
regions are more likely to take up FFA
from the circulation and are less likely to
release them readily (so called “FFA trap-
ping”) (23). Hereby increased peripheral
fat stores may protect other organs, such
as the liver and the pancreas, as well as
skeletal muscle tissue from high FFA ex-
posure. Accumulation of fat in the liver
has been found to be positively associated
with insulin resistance (24,25), and infil-
trating muscle fat in the thigh, which only
accounted for3% of total thigh fat, was
also positively associated with insulin re-
sistance (26). Recent work also points to a
possible role of lipids in -cell deteriora-
tion (“lipotoxicity”) associated with type 2
diabetes (27). The ectopic fat storage hy-
pothesis is also supported by the observa-
tion that adipose tissue deficiency is
accompanied by ectopic fat storage and
related to insulin resistance and diabetes
(28,29). Furthermore, transplantation of
adipose tissue back in lipoatrophic ani-
mals reverses elevated glucose levels, and
leptin-replacement therapy in women
with lipodystrophy improved glycemic
control (30,31).
Adipose tissue is an endocrine gland
that secretes many proteins. Examples in-
clude adiponectin, leptin, resistin, angio-
tensinogen, interleukin-6, tumor necrosis
factor-, adipsin, plasminogen activator
inhibitor-1, and probably many other yet
unknown factors. Regional differences in
secretion of these factors could also be an
alternative or additional explanation for
the observed relationships between adi-
pose tissue and glucose levels. There are
some known differences in secretion be-
tween abdominal subcutaneous and vis-
ceral fat (32–34), but less is known about
differences between gluteal and abdomi-
nal subcutaneous fat.
In men, a significant negative associ-
ation was found between glucose and
HOMA-IR levels and lean mass in the legs,
probably because lean mass in the legs
measured by DXA reflects mainly skeletal
muscle tissue and muscle tissue is one of
the sites of insulin resistance and the main
target of insulin. In women, this negative
association with lean tissue was also
found but was not statistically significant.
The lean mass in the trunk was not nega-
tively associated with glucose levels; it
was even positively associated with fast-
ing glucose levels. However, these results
should be interpreted with caution, be-
cause lean mass in the trunk as measured
by DXA reflects not only muscle mass but
also visceral organ mass (e.g., liver and
intestinal organs).
The main limitation of our study is
that DXA does not allow separate quanti-
fication of intermuscular and subcutane-
ous fat in the legs and visceral fat and
subcutaneous fat in the trunk. The contri-
bution of subcutaneous fat to the total
amount of fat in the legs, however, is rel-
atively large ( 90%) (26). Therefore, the
associations found in our study with fat
mass in the legs are probably mainly due
to the subcutaneous fat depot. As subcu-
taneous fat accounts for the largest fat
component in the trunk, an important
role of subcutaneous trunk fat apart from
the visceral fat cannot be excluded. An-
other possible limitation of DXA is that,
particularly in women, gluteal fat and ab-
dominal fat cannot be perfectly distin-
guished. Possibly, part of the gluteal fat
was included in the trunk region and part
of the abdominal fat was included in the
leg region. Therefore, we may have un-
derestimated the true associations. Fi-
nally, because of the selection of the study
population, subjects with impaired glu-
cose metabolism and diabetes were rela-
tively overrepresented. Adjustment for
glucose tolerance status, however, did not
change the conclusions.
In summary, caution is needed when
interpreting waist and hip circumfer-
ences. Whereas larger waist circumfer-
ence mainly reflects higher fat mass in the
trunk, the hip circumference and WHR
are influenced by both fat and lean mass
from the legs. We also conclude that al-
though higher fat mass in the trunk was
the strongest determinant of disturbed
glucose metabolism, larger fat mass in the
legs and larger lean mass in men only have
a considerable and opposite association
with glucose metabolism. These findings
provide a relevant new insight in the as-
sociation between obesity, body compo-
sition, and type 2 diabetes. Further
investigation of the underlying patho-
physiological mechanism is needed to ex-
plain the negative association of leg fat
with glucose metabolism.
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